Simon handles mainly life sciences patent work with experience in a wide range of sectors including agricultural science, Medtech, Cleantech, pharmaceutical and biotechnology industry sectors.
His work has included advising on:
Simon was ranked as “Highly Recommended” for patent prosecution in ‘IAM Patent1000, 2012, 2013 and 2014, The World’s Leading Patent Practitioners’. Also ranked for EPO prosecution as “one of those European patent attorneys whose first-class achievements garner pan-continental acclaim.”
In 2014, IAM commented: “Sharp and experienced on oppositions” and a “consistently classy performer in the biotechnology field”, Simon Kremer garners glowing notices. “His knowledge of US protection issues sets him apart from the pack“.
Simon is highlighted IAM Patent 1000 2016 with researchers noting “Simon Kremer has been busy refining a patent strategy for WisTa’s treatments for neurodegenerative diseases”. He is also placed on the EPO rankings short list of recommended attorneys.
Simon was recommended in Chambers & Partner 2014 which said “Simon is credited by sources for his “understanding and grasp” of the science underpinning patents”.
Simon is recommended by peers in ‘Managing Intellectual Property’s IP Stars 2015′. “Simon is an absolute pleasure to work with, “ says one.
Simon is recommended for his ‘fortes in Enzymes and biofuels and his intimate familiarity with the ins and outs of US prosecution processes’ in the IAM Patent 1000, 2017.
In 2018, Simon is once again recommended for his “unique knowledge of enzymes and biofuels, and cell and tissue culture” in the IAM Patent 1000. He is again recommended in the EPO rankings short list.
Simon received praise in Chambers & Partners 2016 with one client quoted as saying “He is absolutely indispensable – he has dealt with our patents for years and so understands very well the various nuances of the portfolio.”
Simon has also gained recognition for his work before the EPO. He is featured in the shortlist of recommended attorneys in the IAM Patent 1000, 2017 edition and is also recommended by peers in the Managing Intellectual Property: IP Stars 2017.
Simon is recognised for his patent prosecution work for biotechnology companies in Chambers & Partners UK 2018. One client says: “He is proactive and has been successful for us in obtaining grants of patents and addressing examiners’ objections.”
He deals mainly with patent drafting, prosecution, opposition and appeal before the EPO and various types of due diligence work. He has a great deal of experience with US prosecution, and has attended multiple interviews at the USPTO.
His clients include individual inventors, universities, SMEs, technology transfer organisations, research councils and multinational companies.
Simon is a member of the Chartered Institute of Patent Attorneys Life Sciences Committee and of the Life Sciences Intellectual Property Review Editorial Board.
Simon has a degree in biochemistry from the University of Bristol. His PhD project was focussed in enzymology.
Simon joined Mewburn Ellis LLP in 1997 after working in a Government intellectual property department since 1992. He qualified as a Chartered Patent Attorney in 1997 and a European Patent Attorney in 1996. Simon joined the partnership in 1999.